Jim Simons Organon & Co. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Organon & Co. stock. As of the latest transaction made, Renaissance Technologies LLC holds 239,700 shares of OGN stock, worth $3.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

239,700

Previous 54,100 343.07%

Holding current value

$3.78 Million

Previous $1.12 Million 309.74%

% of portfolio

0.01%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.65 - $23.03 $3.46 Million - $4.27 Million	185,600 Added 343.07%	239,700 $4.59 Million
Q2 2024 Aug 09, 2024	BUY	$17.45 - $21.96 $944,045 - $1.19 Million	54,100 New	54,100 $1.12 Million
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $4.64 Million - $6.65 Million	-279,863 Reduced 85.98%	45,637 $792,000
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $2.95 Million - $3.77 Million	-153,000 Reduced 31.97%	325,500 $6.77 Million
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $447,678 - $670,472	20,900 Added 4.57%	478,500 $11.3 Million
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $9.39 Million - $11.5 Million	-403,000 Reduced 46.83%	457,600 $12.8 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $1.32 Million - $1.93 Million	-56,245 Reduced 6.13%	860,600 $20.1 Million
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $5.31 Million - $6.52 Million	167,660 Added 22.38%	916,845 $30.9 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $17.1 Million - $22.1 Million	561,200 Added 298.53%	749,185 $26.2 Million
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $5.39 Million - $6.98 Million	187,985 New	187,985 $5.72 Million

Others Institutions Holding OGN

# of Institutions

794

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.02B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account